News
LEXINGTON, Ky. (July 19, 2021) — As the SARS-CoV-2 delta variant continues to spread across the United States and hospitals’ COVID-positive intake numbers climb again, many questions remain around both vaccine effectiveness and vaccination rates, and what these numbers could mean moving into the fall.
LEXINGTON, Ky. (July 13, 2021) — A recently published study co-authored by University of Kentucky Sanders-Brown Center on Aging researcher Justin Miller, Ph.D., identifies 11 rare candidate variants for Alzheimer’s disease. Researchers found 19 different families in Utah that suffered from Alzheimer’s disease more frequently than what is considered normal.
The University of Kentucky Center for Appalachian Research in Environmental Sciences (UK-CARES), in partnership with the Center of Excellence in Rural Health (CERH), recently announced the nominees and the winner of the 2021 Community Engagement Award in Environmental Health.
LEXINGTON, Ky. (July 6, 2021) — The Markey Cancer Center at Lexington Clinic location in Richmond, Kentucky, has moved into new, improved clinic space. As of July 2, the clinic is located at 2019 Corporate Dr. in Richmond.
LEXINGTON, Ky. (July 2, 2021) — A new University of Kentucky College of Medicine study suggests that time-restricted eating may be able to help people with Type 2 diabetes reduce nocturnal hypertension, which is characterized by elevated blood pressure at night.
LEXINGTON, Ky. (June 30, 2021) — The University of Kentucky’s Neuroscience Research Priority Area (NRPA) supports a "collaborative matrix," bringing together diverse groups of investigators, trainees and research groups from nine different colleges across the University of Kentucky campus.
LEXINGTON, Ky. (June 24, 2021) — Early in the evening of May 30, 2020, UK HealthCare trauma surgeon Dr. Zachary Warriner prepared an emergency operation to figure out the cause of a bowel obstruction. His patient, a 27-year old man, had come into the emergency department earlier that day with the vague symptoms of severe belly pain and nausea.
Hammodah Alfar is in his second year of graduate school in the UK College of Medicine Department of Molecular and Cellular Biochemistry, with a specialized interest in platelet biology.
He has gained important research experience as a member of the Virus-Induced Thrombosis Alliance (VITAL), led by Beth Garvy, PhD, associate dean for biomedical education, and Sidney Whiteheart, PhD, professor of molecular and cellular biochemistry.
LEXINGTON, Ky. (June 21, 2021) – A new University of Kentucky College of Medicine study will examine how policies that restrict the sale of flavored tobacco products including menthol cigarettes impact health disparities among vulnerable populations.
A five-year, $2.8 million grant from the National Cancer Institute (NCI) will support the study on how local policies impact at-risk groups – including communities of color, low-income populations and youth – that are more likely to use flavored tobacco products.
Juneteenth is observed on June 19, 2021, to commemorate the emancipation of enslaved people in the U.S. On this day, enslaved African-Americans in Galveston, Texas, were notified they had actually been freed almost 2.5 years earlier.
Members of the College of Medicine were asked a series of questions on how they honor Juneteenth.
Kaylin BateyClass of 2023
Q: When did you first become aware of Juneteenth?
Memory Sunday is designated nationally as the second Sunday in June. Memory Sunday was established to raise awareness about Alzheimer’s disease and its impact on the African American community, since their risk of developing Alzheimer’s disease is two to three times higher than white Americans.
A study by several researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) was recently highlighted in AlzForum. The study focuses on polyamines, the nitrogen-packed aliphatic molecules produced by our own cells and found in the foods we eat. They have been described by some as anti-aging generators.
In his 40 years at the University of Kentucky College of Medicine, Michael T. Piascik, PhD, has mentored hundreds of medical students and graduate students while bringing key funding to the college as a researcher to help produce groundbreaking discoveries in pharmacology.
After a long and distinguished career, Dr. Piascik has announced he will retire, effective July 1.
LEXINGTON, Ky. (June 4, 2021) — University of Kentucky Department of Neuroscience Professor Greg Gerhardt, Ph.D., hypothesizes that the balance of glutamate and gamma-aminobutyric acid (GABA) — two main neurotransmitters in the brain — contributes to Alzheimer’s disease and age-related declines in cognition and memory.
LEXINGTON, Ky. (June 1, 2021) — Thanks to a $5.6 million grant from the National Institutes of Health (NIH), a University of Kentucky College of Medicine team will study the culprit behind thoracic aortic aneurysms, which could lead to a treatment for the potentially deadly disease.
LEXINGTON, Ky. (May 26, 2021) — University of Kentucky College of Medicine researcher Cassandra Gipson-Reichardt, Ph.D., has received the College on Problems of Drug Dependence’s (CPDD) 2021 Joseph Cochin Young Investigator Award for Excellence.
The annual award recognizes an investigator under 40 years old who has demonstrated excellence in their field of research and authored several publications. It is one of the most prestigious honors awarded by the CPDD, the longest standing group in the U.S. dedicated to addressing issues of drug dependence and abuse.
LEXINGTON, Ky. (May 26, 2021) – It’s no secret the sun can be damaging to the skin. About 10 years ago, Betty Graham began to learn this the hard way.
After noticing an unusual spot on her leg, a skin cancer screening found eight precancerous lesions. When caught early, these types of lesions can be removed and cured. Graham, at the time an avid tanning bed user, now regrets that behavior.
“Tanning beds are the world’s worst thing for skin cancer,” said Graham.
LEXINGTON, Ky. (May 25, 2021) – The University of Kentucky Markey Cancer Center announces that radiation oncologist Dr. Charles Kunos will join the center and serve as medical director of Markey’s Clinical Research Office (CRO).
Beth Garvy, PhD, and Sidney Whiteheart, PhD, originally planned to study blood clotting in HIV-positive patients when they first approached one another to establish a unified research team. Then COVID-19 emerged, and their focus shifted on the disease that started a global pandemic.